Galanin type 2 receptors regulate neuronal survival, susceptibility to seizures and seizure-induced neurogenesis in the dentate gyrus

The European Journal of Neuroscience
A M MazaratiT Bartfai

Abstract

The neuropeptide galanin has been implicated in inhibiting seizures and protecting hippocampal neurons from excitotoxic injury. In the hippocampus galanin acts through two receptor subtypes, GalR1, expressed in CA1, and GalR2, abundant in dentate gyrus. We developed an approach to induce and to study selective semichronic knockdown of GalR2 in the rat hippocampus. A 50% reduction of GalR2 binding was achieved by continuous infusion of complementary peptide nucleic acid antisense oligonucleotide into the dentate gyrus. This resulted in an increase in the severity of self-sustaining status epilepticus induced by electrical stimulation of the perforant path, induced mild neuronal injury in the dentate hilus, augmented seizure-induced hilar injury and inhibited seizure-induced neurogenesis in the subgranular zone of the dentate gyrus. Our data suggest that in the dentate gyrus, galanin, acting through GalR2, inhibits seizures, promotes viability of hilar interneurons and stimulates seizure-induced neurogenesis. These results are important for understanding the role of galanin and galanin receptor subtypes in the hippocampus both under normal conditions and in excitotoxic injury.

References

Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·E Habert-OrtoliJ F Mayaux
Dec 20, 1994·Proceedings of the National Academy of Sciences of the United States of America·R R JiT Hökfelt
Oct 14, 1994·European Journal of Pharmacology·E HeuilletJ C Blanchard
Mar 15, 1993·European Journal of Pharmacology·S ZiniY Ben-Ari
Nov 1, 1993·Mechanisms of Development·G OliverP Gruss
Mar 22, 1996·Neuroreport·E L GustafsonT A Branchek
Mar 1, 1997·The Journal of Peptide Research : Official Journal of the American Peptide Society·A JuréusT Bartfai
Feb 3, 1999·Annals of the New York Academy of Sciences·B DepczynskiA Cunningham
Feb 3, 1999·Annals of the New York Academy of Sciences·T HökfeltX Zhang
Feb 26, 2000·Trends in Pharmacological Sciences·T A BranchekM W Walker
Apr 13, 2000·The European Journal of Neuroscience·B J KerrS W Thompson
Oct 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·G O'MearaD Wynick
Jul 18, 2001·Brain Research. Molecular Brain Research·A KondratyevK Gale
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·H X LiuT Hökfelt
Aug 17, 2001·Trends in Neurosciences·R E Zigmond
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M KokaiaT Hökfelt
May 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·Külliki SaarUlo Langel
Oct 31, 2002·Journal of Chemical Neuroanatomy·Françoise MennickenDajan O'Donnell
Dec 19, 2002·Brain Research. Molecular Brain Research·Arie Steven JacobyTiina Pauline Iismaa
Jul 16, 2003·Journal of Neurochemistry·Owain W HowellWilliam P Gray
Jul 31, 2003·Epilepsia·Sergueï O FetissovTomas Hökfelt
Sep 5, 2003·Die Naturwissenschaften·Christoph Arenz, Ute Schepers
Nov 12, 2003·The Journal of Pharmacology and Experimental Therapeutics·Xiao-Ying HuaTony L Yaksh
Nov 19, 2003·The European Journal of Neuroscience·En-Ju D LinMatthew J During

❮ Previous
Next ❯

Citations

May 27, 2008·Cellular and Molecular Life Sciences : CMLS·S E CountsE J Mufson
May 19, 2010·Journal of Biomolecular Structure & Dynamics·Z LiuS Zhang
Jan 19, 2013·Stem Cells and Development·Fabienne AgasseDavid P D Woldbye
Nov 28, 2009·Epilepsia·Gunther SperkSusanne Pirker
Aug 2, 2005·Epilepsy Currents·Raman Sankar
May 19, 2005·Molecular and Cellular Biology·Michelle L GottschRobert A Steiner
Jan 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Xiaoying LuTamas Bartfai
Jul 22, 2014·Neuropeptides·G Barreda-GómezR Rodríguez-Puertas
Apr 8, 2014·Molecular Neurobiology·Elke ClynenJean-Michel Rigo
Jul 30, 2015·Expert Opinion on Therapeutic Targets·Krista FreimannÜlo Langel
Dec 23, 2015·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Gaetano Zaccara, Dieter Schmidt
Jan 16, 2016·Current Neurology and Neuroscience Reports·Qin ZhongFeng-Ru Tang
Oct 21, 2009·Biochemical and Biophysical Research Communications·Marisa LouridasMaria Vrontakis
Jun 18, 2009·Neurobiology of Learning and Memory·Jefferson W KinneyTamas Bartfai
May 27, 2009·Neuropeptides·Johan RunessonUlo Langel
Nov 6, 2008·Behavioural Brain Research·Smita Thakker-Varia, Janet Alder
Apr 12, 2008·Molecular and Cellular Endocrinology·William P Gray
Oct 27, 2005·Journal of Neurochemistry·Stefania PirondiLaura Calzà
Dec 19, 2012·Epilepsia·Pablo M Casillas-EspinosaTerence J O'Brien
Oct 12, 2010·Journal of Neuroscience Research·S H Christiansen, D P D Woldbye
Jun 10, 2005·Neuropeptides·Xiaoying LuTamas Bartfai
Nov 30, 2004·Neuropeptides·Andrey M Mazarati
Sep 18, 2012·General and Comparative Endocrinology·John Chi Wang HoFrederick C Leung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Caroline R Elliott-HuntD Wynick
Proceedings of the National Academy of Sciences of the United States of America
T BartfaiJulius Rebek
Trends in Pharmacological Sciences
T A BranchekM W Walker
© 2022 Meta ULC. All rights reserved